Pharmacological profiling of sigma 1 receptor ligands by novel receptor homomer assays.

Pharmacological profiling of sigma 1 receptor ligands by novel receptor homomer assays.
复制标题

DOI:
10.1016/j.neuropharm.2018.01.042
复制
发表时间:
2018-05-01
期刊:
影响因子:
4.7
通讯作者:
Shi L
Shi L
中科院分区:
医学2区
文献类型:
--
作者:
Yano H;Bonifazi A;Xu M;Guthrie DA;Schneck SN;Abramyan AM;Fant AD;Hong WC;Newman AH;Shi L

文献摘要

参考文献

被引文献

相似文献

The sigma 1 receptor (σ1R) is a structurally unique transmembrane protein that functions as a molecular chaperone in the endoplasmic reticulum (ER), and has been implicated in cancer, neuropathic pain, and psychostimulant abuse. Despite physiological and pharmacological significance, mechanistic underpinnings of structure-function relationships of σ1R are poorly understood, and molecular interactions of selective ligands with σ1R have not been elucidated. The recent crystallographic determination of σ1R as a homo-trimer provides the foundation for mechanistic elucidation at the molecular level. Here we report novel bioluminescence resonance energy transfer (BRET) assays that enable analyses of ligand-induced multimerization of σ1R and its interaction with BiP. Haloperidol, PD144418, and 4-PPBP enhanced σ1R homomer BRET signals in a dose dependent manner, suggesting their significant effects in stabilizing σ1R multimerization, whereas (+)-pentazocine and several other ligands do not. In non-denaturing gels, (+)-pentazocine significantly decreased whereas haloperidol increased the fraction of σ1R multimers, consistent with the results from the homomer BRET assay. Further, BRET assays examining heteromeric σ1R-BiP interaction revealed that (+)-pentazocine and haloperidol induced opposite trends of signals. From molecular modeling and simulations of σ1R in complex with the tested ligands, we identified initial clues that may lead to the differed responses of σ1R upon binding of structurally diverse ligands. By combining multiple in vitro pharmacological and in silico molecular biophysical methods, we propose a novel integrative approach to analyze σ1R-ligand binding and its impact on interaction of σ1R with client proteins.
DOI: 10.1016/j.tins.2012.09.007
发表时间: 2012-12
影响因子: 15.9
作者:
Kourrich S;Su TP;Fujimoto M;Bonci A
通讯作者: Bonci A
DOI: 10.1016/j.pharmthera.2010.04.003
发表时间: 2010-09
影响因子: 13.5
作者:
Fishback, James A.;Robson, Matthew J.;Xu, Yan-Tong;Matsumoto, Rae R.
通讯作者: Matsumoto, Rae R.
DOI: 10.1073/pnas.93.15.8072
发表时间: 1996-07-23
影响因子: 11.1
作者:
Hanner, M;Moebius, FF;Glossmann, H
通讯作者: Glossmann, H
DOI: 10.1021/jm970525a
发表时间: 1997-12-19
影响因子: 7.3
作者:
Agoston, GE;Wu, JH;Newman, AH
通讯作者: Newman, AH
DOI: 10.1074/jbc.m116.774075
发表时间: 2017-07-07
影响因子: 4.8
作者:
Hong, Weimin Conrad;Yano, Hideaki;Katz, Jonathan L.
通讯作者: Katz, Jonathan L.